Gene · 51441
Papers3,768
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,768
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unlocking the potential: m6A-RNA methylation in severe epidermolysis bullosa simplex. | Biosci Rep | 2025 | 40700032 | PubTator, text mining | PubMed |
| METTL14 induces ferroptosis to inhibit colorectal cancer progression by inhibiting TRIB3 via an m6A-YTHDF2-dependent manner. | J Mol Histol | 2025 | 40691523 | PubTator, text mining | PubMed |
| Pleckstrin-2 promotes the progression of colorectal cancer via YTHDF2-mediated TYMS mRNA stability. | Cell Mol Life Sci | 2025 | 40682666 | PubTator, text mining | PubMed |
| ALKBH5-mediated NPC2 mRNA m6A demethylation promotes resistance to oxaliplatin in colorectal cancer. | Funct Integr Genomics | 2025 | 40681956 | PubTator, text mining | PubMed |
| Klotho promotes autophagy and alleviates cyclophosphamide-induced ovarian granulosa cell injury by activating AMPK/ULK1 signaling pathway. | Int J Biol Macromol | 2025 | 40664325 | PubTator, text mining | PubMed |
| Decoding RNA-Protein Interactions: Methodological Advances and Emerging Challenges. | Adv Genet (Hoboken) | 2025 | 40657556 | PubTator, text mining | PubMed |
| ALKBH3-regulated m1A of ALDOA potentiates glycolysis and doxorubicin resistance of triple negative breast cancer cells. | Acta Pharm Sin B | 2025 | 40654364 | PubTator, text mining | PubMed |
| Expression of m6A-related factors in pulmonary sarcomatoid carcinoma. | Pathol Res Pract | 2025 | 40651121 | PubTator, text mining | PubMed |
| WTAP-mediated m6A modification promotes drug sensitivity by regulating NR3C1 in prostate cancer. | Sci China Life Sci | 2025 | 40650812 | PubTator, text mining | PubMed |
| Depletion of Fat Mass and Obesity-Associated Protein (FTO) Drives Heterochromatin Loss via Lysine Acetyltransferase 8 (KAT8)-Mediated Remodeling and Spacing Factor 1 (RSF1) Acetylation in Skin Aging. | MedComm (2020) | 2025 | 40636284 | PubTator, text mining | PubMed |
| The role of m6A RNA methylation in a love-hate relationship between porcine rotavirus and host cells. | Cell Biosci | 2025 | 40629467 | PubTator, text mining | PubMed |
| FTO inhibition represses B-cell acute lymphoblastic leukemia progression by inducing nucleolar stress and mitochondrial dysfunction. | Free Radic Biol Med | 2025 | 40623539 | PubTator, text mining | PubMed |
| K542 acetylation promotes YTHDF2 binding to m6A-modified mRNAs and fosters colorectal cancer progression. | Exp Cell Res | 2025 | 40623493 | PubTator, text mining | PubMed |
| Histone lactylation-driven YTHDF2 promotes non-small cell lung cancer cell glycolysis and stemness by recognizing m6A modification of SFRP2. | Biochem Pharmacol | 2025 | 40619016 | PubTator, text mining | PubMed |
| Targeting YTHDF2 with pH-responsive siRNA nanoparticles suppresses MYC m6A modification and restores antitumor immunity in hepatocellular carcinoma. | J Nanobiotechnology | 2025 | 40598231 | PubTator, text mining | PubMed |
| EP300-mediated H3K18la regulation of METTL3 promotes macrophage ferroptosis and atherosclerosis through the m6A modification of SLC7A11. | Biochim Biophys Acta Gen Subj | 2025 | 40588140 | PubTator, text mining | PubMed |
| m6A mRNA demethylase FTO promotes chondrogenic differentiation of human bone marrow mesenchymal stem cells by targeting SMAD3. | Stem Cells | 2025 | 40570063 | PubTator, text mining | PubMed |
| METTL14/YTHDF2 m6A Axis Protects Against M2 Macrophage Polarization in Endometriosis by Regulating KLF4 Stability. | Appl Biochem Biotechnol | 2025 | 40549286 | PubTator, text mining | PubMed |
| RNA Binding Protein YTHDF2 Inhibits Synovial Fibroblast Inflammation and Bone Injury in Rheumatoid Arthritis by Reducing the mRNA Stability of IL-6R. | Kaohsiung J Med Sci | 2025 | 40548546 | PubTator, text mining | PubMed |
| Beyond mRNA degradation: A new role of YTHDF2 in translation. | Mol Cell | 2025 | 40541165 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51441/papers?page=14